Endovascular Ablation of the Right Greater Splanchnic Nerve for the Treatment of Heart Failure with Preserved Ejection Fraction - First-in-human Clinical Trial
In HFpEF, increased sympathetic outflow to the splanchnic venous system causes chronic redistribution of blood volume into the central circulation, which leads to exercise limitations, hemodynamic deterioration, and worsening outcomes. We have previously shown that surgical right greater splanchnic nerve (GSN) ablation in HFpEF leads to a reduction of PCWP, improved quality of life and exercise capacity.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Sanjiv J. Shah, Teona Zirakashvili, Nikoloz Shaburishvili, Giorgi Shaishmelashvili, Horst Sievert, Kolja Sievert, Anisha Bapna, Zoar J. Engelman, Daniel Burkhoff, Tamaz Shaburishvili Source Type: research
More News: Cardiology | Clinical Trials | Heart | Heart Failure | Reflex Sympathetic Dystrophy | Sports Medicine